{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:02Z","timestamp":1794019982799,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jpeds.2023.113598","type":"journal-article","created":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T09:22:30Z","timestamp":1688289750000},"page":"113598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Polysymptomatology and Polypharmacy at End of Life in Patients with Duchenne Muscular Dystrophy"],"prefix":"10.1016","volume":"261","author":[{"given":"Isabella","family":"Ramicone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Whitford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6038-7241","authenticated-orcid":false,"given":"Rachel","family":"Thienprayoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2023.113598_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2023.113598_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nmd.2013.05.008","article-title":"195th ENMC international workshop: newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands","volume":"23","author":"Ellis","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2023.113598_bib3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2023.113598_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nmd.2016.11.012","article-title":"Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in Japan","volume":"27","author":"Saito","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2023.113598_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpeds.2023.113598_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12891-022-05504-5","article-title":"Pain characteristics among individuals with Duchenne muscular dystrophy according to their clinical stage","volume":"23","author":"Kim","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jpeds.2023.113598_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.nmd.2020.09.031","article-title":"Tasks and interfaces in primary and specialized palliative care for Duchenne muscular dystrophy\u2014a patients' perspective","volume":"30","author":"Janisch","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2023.113598_bib8","doi-asserted-by":"crossref","first-page":"e0212437","DOI":"10.1371\/journal.pone.0212437","article-title":"Frequency of reported pain in adult males with muscular dystrophy","volume":"14","author":"Jacques","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2023.113598_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/dmcn.15404","article-title":"Chronic pain, psychological distress, and quality of life in males with Duchenne muscular dystrophy","volume":"65","author":"Huang","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpeds.2023.113598_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejpn.2015.04.005","article-title":"Pain in adolescents with spinal muscular atrophy and Duchenne and Becker muscular dystrophy","volume":"19","author":"Lager","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jpeds.2023.113598_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2023.113598_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpeds.2023.113598_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpeds.2023.113598_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpeds.2023.113598_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.nmd.2012.06.354","article-title":"Bone health in boys with Duchenne muscular dystrophy on long-term daily deflazacort therapy","volume":"22","author":"Mayo","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2023.113598_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2016.11.078","article-title":"Long-term outcome of interdisciplinary management of patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment","volume":"182","author":"Wong","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2023.113598_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0960-8966(01)00307-8","article-title":"Vertebral compression in Duchenne muscular dystrophy following deflazacort","volume":"12","author":"Talim","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2023.113598_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/000992280304200408","article-title":"Vertebral fractures\u00a0in boys with Duchenne muscular dystrophy","volume":"42","author":"Bothwell","year":"2003","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.jpeds.2023.113598_bib19","doi-asserted-by":"crossref","first-page":"e0163779","DOI":"10.1371\/journal.pone.0163779","article-title":"Gastrointestinal dysfunction in patients with Duchenne muscular dystrophy","volume":"11","author":"Lo Cascio","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2023.113598_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpainsymman.2006.09.015","article-title":"Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients","volume":"33","author":"Clemens","year":"2007","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jpeds.2023.113598_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/jpm.2011.0109","article-title":"Dyspnea review for the palliative care professional: assessment, burdens, and etiologies","volume":"14","author":"Kamal","year":"2011","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpeds.2023.113598_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jpm.2011.0110","article-title":"Dyspnea review for the palliative care professional: treatment goals and therapeutic options","volume":"15","author":"Kamal","year":"2012","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpeds.2023.113598_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3747\/co.27.6413","article-title":"Management of dyspnea in palliative care","volume":"27","author":"Crombeen","year":"2020","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jpeds.2023.113598_bib24","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/cncr.32035","article-title":"High-intensity end-of-life care among children, adolescents, and young adults with cancer who die in the hospital: a population-based study from the French national hospital database","volume":"125","author":"Revon-Rivi\u00e8re","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jpeds.2023.113598_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jamaoncol.2015.1953","article-title":"End-of-life care intensity among adolescent and young adult patients with cancer in Kaiser Permanente Southern California","volume":"1","author":"Mack","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jpeds.2023.113598_bib26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/MLR.0000000000000437","article-title":"High intensity of end-of-life care among adolescent and young adult cancer patients in the New York State Medicaid program","volume":"53","author":"Mack","year":"2015","journal-title":"Med Care"},{"key":"10.1016\/j.jpeds.2023.113598_bib27","doi-asserted-by":"crossref","first-page":"e770","DOI":"10.1200\/JOP.2016.020586","article-title":"End-of-life intensity for adolescents and young adults with cancer: a Californian population-based study that shows disparities","volume":"13","author":"Johnston","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jpeds.2023.113598_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncr.33926","article-title":"Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: a population-based study using the IMPACT cohort","volume":"128","author":"Coltin","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jpeds.2023.113598_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jpainsymman.2022.02.084","article-title":"Impact of specialized versus general palliative care on the intensity of medical care at the end of life in adolescents and young adults with cancer: a population-based cohort study","volume":"63","author":"Kassam","year":"2022","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jpeds.2023.113598_bib30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2017.09.078","article-title":"Patterns of care at the end of life for children and young adults with life-threatening complex chronic conditions","volume":"193","author":"DeCourcey","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2023.113598_bib31","doi-asserted-by":"crossref","first-page":"e20182228","DOI":"10.1542\/peds.2018-2228","article-title":"Disparities in inpatient intensity of end-of-life care for complex chronic conditions","volume":"143","author":"Johnston","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2023.113598_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jpainsymman.2015.01.012","article-title":"Measuring what matters: top-ranked quality indicators for hospice and palliative care from the American Academy of Hospice and Palliative Medicine and Hospice and Palliative Nurses Association","volume":"49","author":"Dy","year":"2015","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jpeds.2023.113598_bib34","author":"Meier"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623004614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623004614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:17:24Z","timestamp":1758359844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347623004614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"alternative-id":["S0022347623004614"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.113598","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polysymptomatology and Polypharmacy at End of Life in Patients with Duchenne Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.113598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113598"}}